drugset / Trial / NCT04195997
Multi-center Application of Bivalirudin in Left Atrial Appendage Occlusion
RandomizedParallel-groupSingle-blindTreatment
Summary
The study is an investigator-sponsored, prospective, multicenter, randomized, open-label study designed to compare efficacy and safety between bivalirudin and heparin in patients with non-valvular atrial fibrillation undergoing percutaneous left atrial appendage occlusion.
Timeline
- Start
- 2020-02-01
- Primary completion
- 2020-12-30
- Completion
- 2021-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bivalirudin | Peptide | 0.75 mg/kg | Intravenous |
| Comparator | Heparin | Other / unclassified | 70 iu/kg | — |
| Comparator | Heparin | Other / unclassified | 100 iu/kg | — |
Indications
No indication recorded.